Guru Ownership Trend
Guru Analysis for Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals, Inc. (ARWR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $90.38 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $23.03 M net inflow during the quarter.
Recent activity highlights Ray Dalio who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Arrowhead Pharmaceuticals, Inc. (ARWR)
Major holders include Ken Fisher ($87.09 M), Cliff Asness ($9.78 M), Ray Dalio ($3.98 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.58 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $23.03 M, with 4 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ARWR during the most recent reporting period.
Yes, 1 managers opened new positions in ARWR, and 3 increased their existing holdings. The total reported buy value was $23.03 M.